nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosuvastatin—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.0799	0.102	CbGbCtD
Rosuvastatin—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0772	0.0985	CbGbCtD
Rosuvastatin—ABCB11—Vincristine—peripheral nervous system neoplasm	0.0693	0.0884	CbGbCtD
Rosuvastatin—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.0579	0.0739	CbGbCtD
Rosuvastatin—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0535	0.0683	CbGbCtD
Rosuvastatin—ABCC1—Vincristine—peripheral nervous system neoplasm	0.0492	0.0628	CbGbCtD
Rosuvastatin—ABCC1—Etoposide—peripheral nervous system neoplasm	0.0451	0.0576	CbGbCtD
Rosuvastatin—ABCB11—Doxorubicin—peripheral nervous system neoplasm	0.0433	0.0553	CbGbCtD
Rosuvastatin—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0397	0.0507	CbGbCtD
Rosuvastatin—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0329	0.042	CbGbCtD
Rosuvastatin—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.0308	0.0393	CbGbCtD
Rosuvastatin—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0307	0.0392	CbGbCtD
Rosuvastatin—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0302	0.0385	CbGbCtD
Rosuvastatin—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0267	0.034	CbGbCtD
Rosuvastatin—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.0206	0.0263	CbGbCtD
Rosuvastatin—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0182	0.0233	CbGbCtD
Rosuvastatin—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0167	0.0213	CbGbCtD
Rosuvastatin—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0167	0.0213	CbGbCtD
Rosuvastatin—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0155	0.0198	CbGbCtD
Rosuvastatin—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0114	0.0146	CbGbCtD
Rosuvastatin—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00712	0.00908	CbGbCtD
Rosuvastatin—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00652	0.00832	CbGbCtD
Rosuvastatin—SLC7A11—forelimb zeugopod—peripheral nervous system neoplasm	0.00546	0.525	CbGeAlD
Rosuvastatin—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00445	0.00568	CbGbCtD
Rosuvastatin—SLC7A11—tongue—peripheral nervous system neoplasm	0.00147	0.141	CbGeAlD
Rosuvastatin—SLCO2B1—ganglion—peripheral nervous system neoplasm	0.000781	0.0751	CbGeAlD
Rosuvastatin—Pitavastatin—ABCB1—peripheral nervous system neoplasm	0.00065	1	CrCbGaD
Rosuvastatin—HMGCR—trigeminal ganglion—peripheral nervous system neoplasm	0.000453	0.0436	CbGeAlD
Rosuvastatin—HMGCR—parotid gland—peripheral nervous system neoplasm	0.000427	0.0411	CbGeAlD
Rosuvastatin—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.0004	0.00218	CcSEcCtD
Rosuvastatin—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.0004	0.00218	CcSEcCtD
Rosuvastatin—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.000395	0.00215	CcSEcCtD
Rosuvastatin—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.000395	0.00215	CcSEcCtD
Rosuvastatin—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.000392	0.00214	CcSEcCtD
Rosuvastatin—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.000392	0.00214	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Etoposide—peripheral nervous system neoplasm	0.000391	0.00213	CcSEcCtD
Rosuvastatin—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000387	0.00211	CcSEcCtD
Rosuvastatin—Pain—Topotecan—peripheral nervous system neoplasm	0.000384	0.00209	CcSEcCtD
Rosuvastatin—Constipation—Topotecan—peripheral nervous system neoplasm	0.000384	0.00209	CcSEcCtD
Rosuvastatin—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000381	0.00208	CcSEcCtD
Rosuvastatin—Pain—Isotretinoin—peripheral nervous system neoplasm	0.000381	0.00208	CcSEcCtD
Rosuvastatin—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000381	0.00208	CcSEcCtD
Rosuvastatin—Pain—Tretinoin—peripheral nervous system neoplasm	0.000381	0.00208	CcSEcCtD
Rosuvastatin—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.00038	0.00207	CcSEcCtD
Rosuvastatin—Pain—Melphalan—peripheral nervous system neoplasm	0.000376	0.00205	CcSEcCtD
Rosuvastatin—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00037	0.00202	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000367	0.002	CcSEcCtD
Rosuvastatin—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000367	0.002	CcSEcCtD
Rosuvastatin—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000367	0.002	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000364	0.00198	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000364	0.00198	CcSEcCtD
Rosuvastatin—Hypertonia—Epirubicin—peripheral nervous system neoplasm	0.000363	0.00198	CcSEcCtD
Rosuvastatin—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000362	0.00197	CcSEcCtD
Rosuvastatin—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.000362	0.00197	CcSEcCtD
Rosuvastatin—Cough—Alitretinoin—peripheral nervous system neoplasm	0.000361	0.00197	CcSEcCtD
Rosuvastatin—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000357	0.00194	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000357	0.00194	CcSEcCtD
Rosuvastatin—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000355	0.00193	CcSEcCtD
Rosuvastatin—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000354	0.00193	CcSEcCtD
Rosuvastatin—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000354	0.00193	CcSEcCtD
Rosuvastatin—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.000352	0.00192	CcSEcCtD
Rosuvastatin—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.000352	0.00192	CcSEcCtD
Rosuvastatin—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000352	0.00192	CcSEcCtD
Rosuvastatin—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000352	0.00192	CcSEcCtD
Rosuvastatin—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000349	0.0019	CcSEcCtD
Rosuvastatin—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.000347	0.00189	CcSEcCtD
Rosuvastatin—Diabetes mellitus—Epirubicin—peripheral nervous system neoplasm	0.000346	0.00188	CcSEcCtD
Rosuvastatin—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00034	0.00185	CcSEcCtD
Rosuvastatin—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000339	0.00185	CcSEcCtD
Rosuvastatin—Hypertonia—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.00183	CcSEcCtD
Rosuvastatin—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000335	0.00183	CcSEcCtD
Rosuvastatin—Hepatic failure—Epirubicin—peripheral nervous system neoplasm	0.000334	0.00182	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000332	0.00181	CcSEcCtD
Rosuvastatin—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000331	0.0018	CcSEcCtD
Rosuvastatin—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000331	0.0018	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000331	0.0018	CcSEcCtD
Rosuvastatin—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000328	0.00179	CcSEcCtD
Rosuvastatin—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000328	0.00179	CcSEcCtD
Rosuvastatin—Renal failure acute—Epirubicin—peripheral nervous system neoplasm	0.000326	0.00177	CcSEcCtD
Rosuvastatin—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000324	0.00176	CcSEcCtD
Rosuvastatin—Infection—Vincristine—peripheral nervous system neoplasm	0.000323	0.00176	CcSEcCtD
Rosuvastatin—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000322	0.00176	CcSEcCtD
Rosuvastatin—Diabetes mellitus—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.00174	CcSEcCtD
Rosuvastatin—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00032	0.00174	CcSEcCtD
Rosuvastatin—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00032	0.00174	CcSEcCtD
Rosuvastatin—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000319	0.00174	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000319	0.00174	CcSEcCtD
Rosuvastatin—SLC7A11—cerebellum—peripheral nervous system neoplasm	0.000318	0.0306	CbGeAlD
Rosuvastatin—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000318	0.00173	CcSEcCtD
Rosuvastatin—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000315	0.00172	CcSEcCtD
Rosuvastatin—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000315	0.00172	CcSEcCtD
Rosuvastatin—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000315	0.00172	CcSEcCtD
Rosuvastatin—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000311	0.0017	CcSEcCtD
Rosuvastatin—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000311	0.00169	CcSEcCtD
Rosuvastatin—Hepatic failure—Doxorubicin—peripheral nervous system neoplasm	0.000309	0.00169	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000308	0.00168	CcSEcCtD
Rosuvastatin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000307	0.00167	CcSEcCtD
Rosuvastatin—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000305	0.00166	CcSEcCtD
Rosuvastatin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000305	0.00166	CcSEcCtD
Rosuvastatin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000305	0.00166	CcSEcCtD
Rosuvastatin—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000303	0.00165	CcSEcCtD
Rosuvastatin—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.00164	CcSEcCtD
Rosuvastatin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000301	0.00164	CcSEcCtD
Rosuvastatin—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.0003	0.00163	CcSEcCtD
Rosuvastatin—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.0003	0.00163	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000298	0.00162	CcSEcCtD
Rosuvastatin—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000297	0.00162	CcSEcCtD
Rosuvastatin—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000297	0.00162	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000296	0.00161	CcSEcCtD
Rosuvastatin—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000295	0.0016	CcSEcCtD
Rosuvastatin—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000295	0.0016	CcSEcCtD
Rosuvastatin—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000294	0.0016	CcSEcCtD
Rosuvastatin—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000292	0.00159	CcSEcCtD
Rosuvastatin—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000289	0.00157	CcSEcCtD
Rosuvastatin—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000289	0.00157	CcSEcCtD
Rosuvastatin—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000288	0.00157	CcSEcCtD
Rosuvastatin—Infection—Cisplatin—peripheral nervous system neoplasm	0.000286	0.00156	CcSEcCtD
Rosuvastatin—Rash—Topotecan—peripheral nervous system neoplasm	0.000283	0.00154	CcSEcCtD
Rosuvastatin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000283	0.00154	CcSEcCtD
Rosuvastatin—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000282	0.00154	CcSEcCtD
Rosuvastatin—Cough—Etoposide—peripheral nervous system neoplasm	0.000282	0.00153	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000282	0.00153	CcSEcCtD
Rosuvastatin—Headache—Topotecan—peripheral nervous system neoplasm	0.000281	0.00153	CcSEcCtD
Rosuvastatin—Rash—Tretinoin—peripheral nervous system neoplasm	0.000281	0.00153	CcSEcCtD
Rosuvastatin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000281	0.00153	CcSEcCtD
Rosuvastatin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000281	0.00153	CcSEcCtD
Rosuvastatin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000281	0.00153	CcSEcCtD
Rosuvastatin—Headache—Tretinoin—peripheral nervous system neoplasm	0.000279	0.00152	CcSEcCtD
Rosuvastatin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000279	0.00152	CcSEcCtD
Rosuvastatin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000278	0.00152	CcSEcCtD
Rosuvastatin—Pain—Vincristine—peripheral nervous system neoplasm	0.000278	0.00152	CcSEcCtD
Rosuvastatin—Constipation—Vincristine—peripheral nervous system neoplasm	0.000278	0.00152	CcSEcCtD
Rosuvastatin—Rash—Melphalan—peripheral nervous system neoplasm	0.000277	0.00151	CcSEcCtD
Rosuvastatin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000277	0.00151	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000276	0.0015	CcSEcCtD
Rosuvastatin—ABCC1—parotid gland—peripheral nervous system neoplasm	0.000273	0.0263	CbGeAlD
Rosuvastatin—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000272	0.00148	CcSEcCtD
Rosuvastatin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000268	0.00146	CcSEcCtD
Rosuvastatin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000268	0.00146	CcSEcCtD
Rosuvastatin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000267	0.00145	CcSEcCtD
Rosuvastatin—Nausea—Topotecan—peripheral nervous system neoplasm	0.000267	0.00145	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000266	0.00145	CcSEcCtD
Rosuvastatin—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000266	0.00145	CcSEcCtD
Rosuvastatin—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000265	0.00144	CcSEcCtD
Rosuvastatin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000265	0.00144	CcSEcCtD
Rosuvastatin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000265	0.00144	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000262	0.00143	CcSEcCtD
Rosuvastatin—Infection—Etoposide—peripheral nervous system neoplasm	0.000262	0.00143	CcSEcCtD
Rosuvastatin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000261	0.00142	CcSEcCtD
Rosuvastatin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000261	0.00142	CcSEcCtD
Rosuvastatin—Influenza—Epirubicin—peripheral nervous system neoplasm	0.00026	0.00142	CcSEcCtD
Rosuvastatin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000258	0.00141	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000258	0.00141	CcSEcCtD
Rosuvastatin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000257	0.0014	CcSEcCtD
Rosuvastatin—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000255	0.00139	CcSEcCtD
Rosuvastatin—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.00137	CcSEcCtD
Rosuvastatin—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.00025	0.00136	CcSEcCtD
Rosuvastatin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000249	0.00136	CcSEcCtD
Rosuvastatin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000249	0.00135	CcSEcCtD
Rosuvastatin—Pain—Cisplatin—peripheral nervous system neoplasm	0.000246	0.00134	CcSEcCtD
Rosuvastatin—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.00134	CcSEcCtD
Rosuvastatin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000242	0.00132	CcSEcCtD
Rosuvastatin—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.00131	CcSEcCtD
Rosuvastatin—ABCG2—trigeminal ganglion—peripheral nervous system neoplasm	0.00024	0.0231	CbGeAlD
Rosuvastatin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00024	0.00131	CcSEcCtD
Rosuvastatin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000239	0.0013	CcSEcCtD
Rosuvastatin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000237	0.00129	CcSEcCtD
Rosuvastatin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000237	0.00129	CcSEcCtD
Rosuvastatin—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.00128	CcSEcCtD
Rosuvastatin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000233	0.00127	CcSEcCtD
Rosuvastatin—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.00126	CcSEcCtD
Rosuvastatin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000231	0.00126	CcSEcCtD
Rosuvastatin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00023	0.00125	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000227	0.00124	CcSEcCtD
Rosuvastatin—ABCG2—parotid gland—peripheral nervous system neoplasm	0.000226	0.0218	CbGeAlD
Rosuvastatin—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000226	0.00123	CcSEcCtD
Rosuvastatin—Pain—Etoposide—peripheral nervous system neoplasm	0.000225	0.00123	CcSEcCtD
Rosuvastatin—Constipation—Etoposide—peripheral nervous system neoplasm	0.000225	0.00123	CcSEcCtD
Rosuvastatin—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000225	0.00123	CcSEcCtD
Rosuvastatin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000223	0.00122	CcSEcCtD
Rosuvastatin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000223	0.00121	CcSEcCtD
Rosuvastatin—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000221	0.0012	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000219	0.00119	CcSEcCtD
Rosuvastatin—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000217	0.00118	CcSEcCtD
Rosuvastatin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000217	0.00118	CcSEcCtD
Rosuvastatin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000216	0.00118	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000215	0.00117	CcSEcCtD
Rosuvastatin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000215	0.00117	CcSEcCtD
Rosuvastatin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000213	0.00116	CcSEcCtD
Rosuvastatin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000213	0.00116	CcSEcCtD
Rosuvastatin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000212	0.00115	CcSEcCtD
Rosuvastatin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000212	0.00115	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.00114	CcSEcCtD
Rosuvastatin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000209	0.00114	CcSEcCtD
Rosuvastatin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.00114	CcSEcCtD
Rosuvastatin—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000208	0.00114	CcSEcCtD
Rosuvastatin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000208	0.00113	CcSEcCtD
Rosuvastatin—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.00113	CcSEcCtD
Rosuvastatin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000208	0.00113	CcSEcCtD
Rosuvastatin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000206	0.00112	CcSEcCtD
Rosuvastatin—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000206	0.00112	CcSEcCtD
Rosuvastatin—Rash—Vincristine—peripheral nervous system neoplasm	0.000205	0.00112	CcSEcCtD
Rosuvastatin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000205	0.00112	CcSEcCtD
Rosuvastatin—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.00111	CcSEcCtD
Rosuvastatin—Headache—Vincristine—peripheral nervous system neoplasm	0.000204	0.00111	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.0011	CcSEcCtD
Rosuvastatin—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.0011	CcSEcCtD
Rosuvastatin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000201	0.00109	CcSEcCtD
Rosuvastatin—HMGCR—cerebellum—peripheral nervous system neoplasm	0.000198	0.019	CbGeAlD
Rosuvastatin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000197	0.00107	CcSEcCtD
Rosuvastatin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000194	0.00106	CcSEcCtD
Rosuvastatin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000193	0.00105	CcSEcCtD
Rosuvastatin—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.00105	CcSEcCtD
Rosuvastatin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.00105	CcSEcCtD
Rosuvastatin—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.00104	CcSEcCtD
Rosuvastatin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000189	0.00103	CcSEcCtD
Rosuvastatin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000186	0.00102	CcSEcCtD
Rosuvastatin—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000186	0.00101	CcSEcCtD
Rosuvastatin—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000992	CcSEcCtD
Rosuvastatin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000181	0.000988	CcSEcCtD
Rosuvastatin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000181	0.000987	CcSEcCtD
Rosuvastatin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00018	0.000982	CcSEcCtD
Rosuvastatin—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000972	CcSEcCtD
Rosuvastatin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000174	0.000949	CcSEcCtD
Rosuvastatin—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000936	CcSEcCtD
Rosuvastatin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000171	0.000931	CcSEcCtD
Rosuvastatin—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000918	CcSEcCtD
Rosuvastatin—SLCO2B1—cerebellum—peripheral nervous system neoplasm	0.000167	0.0161	CbGeAlD
Rosuvastatin—Rash—Etoposide—peripheral nervous system neoplasm	0.000166	0.000905	CcSEcCtD
Rosuvastatin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000166	0.000904	CcSEcCtD
Rosuvastatin—Headache—Etoposide—peripheral nervous system neoplasm	0.000165	0.000899	CcSEcCtD
Rosuvastatin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000899	CcSEcCtD
Rosuvastatin—Cough—Epirubicin—peripheral nervous system neoplasm	0.000158	0.00086	CcSEcCtD
Rosuvastatin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000157	0.000853	CcSEcCtD
Rosuvastatin—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000839	CcSEcCtD
Rosuvastatin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000839	CcSEcCtD
Rosuvastatin—SLCO1A2—cerebellum—peripheral nervous system neoplasm	0.000154	0.0148	CbGeAlD
Rosuvastatin—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000811	CcSEcCtD
Rosuvastatin—Infection—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000799	CcSEcCtD
Rosuvastatin—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000796	CcSEcCtD
Rosuvastatin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000789	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000788	CcSEcCtD
Rosuvastatin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000777	CcSEcCtD
Rosuvastatin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000777	CcSEcCtD
Rosuvastatin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000751	CcSEcCtD
Rosuvastatin—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.00074	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000733	CcSEcCtD
Rosuvastatin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.00073	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000729	CcSEcCtD
Rosuvastatin—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000728	CcSEcCtD
Rosuvastatin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000723	CcSEcCtD
Rosuvastatin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000708	CcSEcCtD
Rosuvastatin—ABCC1—cerebellum—peripheral nervous system neoplasm	0.000126	0.0122	CbGeAlD
Rosuvastatin—Pain—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000688	CcSEcCtD
Rosuvastatin—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000688	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000678	CcSEcCtD
Rosuvastatin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000673	CcSEcCtD
Rosuvastatin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000669	CcSEcCtD
Rosuvastatin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000663	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000658	CcSEcCtD
Rosuvastatin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000655	CcSEcCtD
Rosuvastatin—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000639	CcSEcCtD
Rosuvastatin—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000637	CcSEcCtD
Rosuvastatin—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000637	CcSEcCtD
Rosuvastatin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000636	CcSEcCtD
Rosuvastatin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000614	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000609	CcSEcCtD
Rosuvastatin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000593	CcSEcCtD
Rosuvastatin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000592	CcSEcCtD
Rosuvastatin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000589	CcSEcCtD
Rosuvastatin—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000577	CcSEcCtD
Rosuvastatin—ABCG2—cerebellum—peripheral nervous system neoplasm	0.000105	0.0101	CbGeAlD
Rosuvastatin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000569	CcSEcCtD
Rosuvastatin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000551	CcSEcCtD
Rosuvastatin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000549	CcSEcCtD
Rosuvastatin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	9.81e-05	0.000534	CcSEcCtD
Rosuvastatin—Dizziness—Epirubicin—peripheral nervous system neoplasm	9.77e-05	0.000532	CcSEcCtD
Rosuvastatin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	9.67e-05	0.000527	CcSEcCtD
Rosuvastatin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	9.35e-05	0.000509	CcSEcCtD
Rosuvastatin—Rash—Epirubicin—peripheral nervous system neoplasm	9.31e-05	0.000507	CcSEcCtD
Rosuvastatin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	9.31e-05	0.000507	CcSEcCtD
Rosuvastatin—Headache—Epirubicin—peripheral nervous system neoplasm	9.25e-05	0.000504	CcSEcCtD
Rosuvastatin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	9.04e-05	0.000492	CcSEcCtD
Rosuvastatin—Nausea—Epirubicin—peripheral nervous system neoplasm	8.77e-05	0.000478	CcSEcCtD
Rosuvastatin—Rash—Doxorubicin—peripheral nervous system neoplasm	8.62e-05	0.000469	CcSEcCtD
Rosuvastatin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	8.61e-05	0.000469	CcSEcCtD
Rosuvastatin—Headache—Doxorubicin—peripheral nervous system neoplasm	8.56e-05	0.000466	CcSEcCtD
Rosuvastatin—SLC7A11—Hemostasis—KNG1—peripheral nervous system neoplasm	8.25e-05	0.00379	CbGpPWpGaD
Rosuvastatin—SLC7A11—Cell surface interactions at the vascular wall—HRAS—peripheral nervous system neoplasm	8.14e-05	0.00373	CbGpPWpGaD
Rosuvastatin—Nausea—Doxorubicin—peripheral nervous system neoplasm	8.12e-05	0.000442	CcSEcCtD
Rosuvastatin—ALB—Platelet degranulation—KNG1—peripheral nervous system neoplasm	8.07e-05	0.0037	CbGpPWpGaD
Rosuvastatin—ABCC4—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	7.91e-05	0.00363	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.81e-05	0.00358	CbGpPWpGaD
Rosuvastatin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	7.78e-05	0.00357	CbGpPWpGaD
Rosuvastatin—SLC7A11—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	7.77e-05	0.00356	CbGpPWpGaD
Rosuvastatin—ALB—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	7.69e-05	0.00353	CbGpPWpGaD
Rosuvastatin—ABCG2—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	7.42e-05	0.00341	CbGpPWpGaD
Rosuvastatin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	7.41e-05	0.0034	CbGpPWpGaD
Rosuvastatin—HMGCR—SREBP signalling—AKT1—peripheral nervous system neoplasm	7.27e-05	0.00333	CbGpPWpGaD
Rosuvastatin—HMGCR—AMPK Signaling—AKT1—peripheral nervous system neoplasm	7.27e-05	0.00333	CbGpPWpGaD
Rosuvastatin—ABCC4—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	7.25e-05	0.00333	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—GNAS—peripheral nervous system neoplasm	7.22e-05	0.00331	CbGpPWpGaD
Rosuvastatin—HMGCR—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	7.17e-05	0.00329	CbGpPWpGaD
Rosuvastatin—SLCO1A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	6.99e-05	0.00321	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.98e-05	0.0032	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—HGF—peripheral nervous system neoplasm	6.88e-05	0.00315	CbGpPWpGaD
Rosuvastatin—ALB—Platelet degranulation—HGF—peripheral nervous system neoplasm	6.72e-05	0.00308	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.71e-05	0.00308	CbGpPWpGaD
Rosuvastatin—ABCC4—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	6.59e-05	0.00302	CbGpPWpGaD
Rosuvastatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	6.59e-05	0.00302	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	6.49e-05	0.00298	CbGpPWpGaD
Rosuvastatin—ALB—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	6.4e-05	0.00294	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.28e-05	0.00288	CbGpPWpGaD
Rosuvastatin—SLC7A11—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	6.25e-05	0.00287	CbGpPWpGaD
Rosuvastatin—SLC7A11—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	6.13e-05	0.00281	CbGpPWpGaD
Rosuvastatin—ABCC1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.04e-05	0.00277	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—HSD17B12—peripheral nervous system neoplasm	6e-05	0.00275	CbGpPWpGaD
Rosuvastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	5.98e-05	0.00274	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.97e-05	0.00274	CbGpPWpGaD
Rosuvastatin—SLCO2B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.79e-05	0.00266	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.74e-05	0.00263	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.64e-05	0.00259	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—GNS—peripheral nervous system neoplasm	5.64e-05	0.00259	CbGpPWpGaD
Rosuvastatin—HMGCR—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	5.6e-05	0.00257	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.52e-05	0.00253	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—NME1—peripheral nervous system neoplasm	5.41e-05	0.00248	CbGpPWpGaD
Rosuvastatin—ABCG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.32e-05	0.00244	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—COX2—peripheral nervous system neoplasm	5.21e-05	0.00239	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	5.17e-05	0.00237	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—PTPN11—peripheral nervous system neoplasm	5.02e-05	0.0023	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.98e-05	0.00229	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.71e-05	0.00216	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.69e-05	0.00215	CbGpPWpGaD
Rosuvastatin—SLCO2B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.66e-05	0.00214	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	4.64e-05	0.00213	CbGpPWpGaD
Rosuvastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	4.6e-05	0.00211	CbGpPWpGaD
Rosuvastatin—SLCO2B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.57e-05	0.0021	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.52e-05	0.00207	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—IFNB1—peripheral nervous system neoplasm	4.4e-05	0.00202	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—GNS—peripheral nervous system neoplasm	4.34e-05	0.00199	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.24e-05	0.00195	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	4.23e-05	0.00194	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—NME1—peripheral nervous system neoplasm	4.16e-05	0.00191	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—GNS—peripheral nervous system neoplasm	4.08e-05	0.00187	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—KNG1—peripheral nervous system neoplasm	4.08e-05	0.00187	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.03e-05	0.00185	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—COX2—peripheral nervous system neoplasm	4e-05	0.00184	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.96e-05	0.00182	CbGpPWpGaD
Rosuvastatin—ABCC4—Ectoderm Differentiation—MYC—peripheral nervous system neoplasm	3.92e-05	0.0018	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.92e-05	0.0018	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—NME1—peripheral nervous system neoplasm	3.91e-05	0.00179	CbGpPWpGaD
Rosuvastatin—HMGCR—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	3.88e-05	0.00178	CbGpPWpGaD
Rosuvastatin—ABCC4—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.84e-05	0.00176	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—COX2—peripheral nervous system neoplasm	3.77e-05	0.00173	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.73e-05	0.00171	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—GNS—peripheral nervous system neoplasm	3.66e-05	0.00168	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.64e-05	0.00167	CbGpPWpGaD
Rosuvastatin—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	3.6e-05	0.00165	CbGpPWpGaD
Rosuvastatin—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	3.58e-05	0.00164	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.57e-05	0.00164	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—GNAS—peripheral nervous system neoplasm	3.56e-05	0.00164	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.55e-05	0.00163	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.52e-05	0.00162	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—ENO2—peripheral nervous system neoplasm	3.42e-05	0.00157	CbGpPWpGaD
Rosuvastatin—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	3.42e-05	0.00157	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.41e-05	0.00156	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—GNS—peripheral nervous system neoplasm	3.41e-05	0.00156	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—HGF—peripheral nervous system neoplasm	3.4e-05	0.00156	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.35e-05	0.00154	CbGpPWpGaD
Rosuvastatin—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.28e-05	0.0015	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—NME1—peripheral nervous system neoplasm	3.27e-05	0.0015	CbGpPWpGaD
Rosuvastatin—ABCC1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.2e-05	0.00147	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—COX2—peripheral nervous system neoplasm	3.14e-05	0.00144	CbGpPWpGaD
Rosuvastatin—ABCC4—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.09e-05	0.00142	CbGpPWpGaD
Rosuvastatin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	3.07e-05	0.00141	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—GNS—peripheral nervous system neoplasm	3.07e-05	0.00141	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.06e-05	0.0014	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.04e-05	0.00139	CbGpPWpGaD
Rosuvastatin—ABCC4—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.03e-05	0.00139	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—NRAS—peripheral nervous system neoplasm	3.02e-05	0.00138	CbGpPWpGaD
Rosuvastatin—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	2.98e-05	0.00137	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—NME1—peripheral nervous system neoplasm	2.94e-05	0.00135	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—GNS—peripheral nervous system neoplasm	2.91e-05	0.00134	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—BCHE—peripheral nervous system neoplasm	2.89e-05	0.00133	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.86e-05	0.00131	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—COX2—peripheral nervous system neoplasm	2.83e-05	0.0013	CbGpPWpGaD
Rosuvastatin—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.81e-05	0.00129	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.8e-05	0.00129	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—NME1—peripheral nervous system neoplasm	2.79e-05	0.00128	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.79e-05	0.00128	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.76e-05	0.00126	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—TH—peripheral nervous system neoplasm	2.72e-05	0.00125	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	2.7e-05	0.00124	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—COX2—peripheral nervous system neoplasm	2.69e-05	0.00123	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.67e-05	0.00123	CbGpPWpGaD
Rosuvastatin—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	2.63e-05	0.00121	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—ENO2—peripheral nervous system neoplasm	2.63e-05	0.00121	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	2.59e-05	0.00119	CbGpPWpGaD
Rosuvastatin—ABCC1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.57e-05	0.00118	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—PPP3R1—peripheral nervous system neoplasm	2.56e-05	0.00117	CbGpPWpGaD
Rosuvastatin—ABCC1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.52e-05	0.00116	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	2.49e-05	0.00114	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—PTPN11—peripheral nervous system neoplasm	2.48e-05	0.00114	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—ENO2—peripheral nervous system neoplasm	2.47e-05	0.00113	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.44e-05	0.00112	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.4e-05	0.0011	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—TP53—peripheral nervous system neoplasm	2.31e-05	0.00106	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.3e-05	0.00106	CbGpPWpGaD
Rosuvastatin—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.26e-05	0.00104	CbGpPWpGaD
Rosuvastatin—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.22e-05	0.00102	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—BCHE—peripheral nervous system neoplasm	2.22e-05	0.00102	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—GNAS—peripheral nervous system neoplasm	2.22e-05	0.00102	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—ENO2—peripheral nervous system neoplasm	2.22e-05	0.00102	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—HRAS—peripheral nervous system neoplasm	2.21e-05	0.00101	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—ABCB1—peripheral nervous system neoplasm	2.18e-05	0.000998	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.12e-05	0.000972	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—BCHE—peripheral nervous system neoplasm	2.09e-05	0.000958	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—TH—peripheral nervous system neoplasm	2.09e-05	0.000957	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.07e-05	0.000948	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—ENO2—peripheral nervous system neoplasm	2.06e-05	0.000947	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.99e-05	0.000914	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	1.99e-05	0.000913	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—TH—peripheral nervous system neoplasm	1.96e-05	0.000901	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—AKT1—peripheral nervous system neoplasm	1.95e-05	0.000894	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	1.93e-05	0.000887	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.91e-05	0.000878	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.88e-05	0.000865	CbGpPWpGaD
Rosuvastatin—ABCC4—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.87e-05	0.000856	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—ENO2—peripheral nervous system neoplasm	1.86e-05	0.000852	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	1.85e-05	0.00085	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	1.84e-05	0.000846	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.84e-05	0.000844	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—SLC2A1—peripheral nervous system neoplasm	1.79e-05	0.00082	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	1.78e-05	0.000818	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—ENO2—peripheral nervous system neoplasm	1.77e-05	0.00081	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.74e-05	0.0008	CbGpPWpGaD
Rosuvastatin—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.74e-05	0.000796	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.72e-05	0.000788	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—GNAS—peripheral nervous system neoplasm	1.7e-05	0.000782	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.67e-05	0.000767	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—GNS—peripheral nervous system neoplasm	1.66e-05	0.000764	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.66e-05	0.000763	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—TH—peripheral nervous system neoplasm	1.64e-05	0.000752	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	1.63e-05	0.00075	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	1.61e-05	0.00074	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—GNAS—peripheral nervous system neoplasm	1.6e-05	0.000736	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—NME1—peripheral nervous system neoplasm	1.6e-05	0.000732	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—ABCB1—peripheral nervous system neoplasm	1.57e-05	0.000722	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—BCHE—peripheral nervous system neoplasm	1.57e-05	0.00072	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.57e-05	0.000719	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	1.54e-05	0.000705	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—COX2—peripheral nervous system neoplasm	1.54e-05	0.000705	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.5e-05	0.000687	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	1.49e-05	0.000686	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—BCHE—peripheral nervous system neoplasm	1.49e-05	0.000684	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—NRAS—peripheral nervous system neoplasm	1.49e-05	0.000683	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—TH—peripheral nervous system neoplasm	1.48e-05	0.000677	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	1.43e-05	0.000657	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.42e-05	0.000653	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—TH—peripheral nervous system neoplasm	1.4e-05	0.000643	CbGpPWpGaD
Rosuvastatin—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.4e-05	0.000641	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	1.38e-05	0.000634	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	1.38e-05	0.000633	CbGpPWpGaD
Rosuvastatin—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.37e-05	0.000629	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.36e-05	0.000625	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.34e-05	0.000614	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.32e-05	0.000604	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.31e-05	0.000603	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	1.31e-05	0.000599	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	1.3e-05	0.000596	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	1.26e-05	0.000577	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.24e-05	0.00057	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—GNAS—peripheral nervous system neoplasm	1.2e-05	0.000553	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.18e-05	0.000542	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	1.17e-05	0.000537	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—GNAS—peripheral nervous system neoplasm	1.14e-05	0.000525	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—TP53—peripheral nervous system neoplasm	1.14e-05	0.000523	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.12e-05	0.000515	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	1.12e-05	0.000514	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—HRAS—peripheral nervous system neoplasm	1.09e-05	0.0005	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	1.06e-05	0.000486	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.04e-05	0.000477	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	1.01e-05	0.000463	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—PTPN11—peripheral nervous system neoplasm	1e-05	0.000459	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	9.89e-06	0.000454	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—AKT1—peripheral nervous system neoplasm	9.62e-06	0.000441	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.44e-06	0.000433	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	9.3e-06	0.000427	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	9.05e-06	0.000415	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	8.99e-06	0.000412	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	8.61e-06	0.000395	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	8.52e-06	0.000391	CbGpPWpGaD
Rosuvastatin—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	8.45e-06	0.000388	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	8.29e-06	0.00038	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	8.25e-06	0.000379	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.13e-06	0.000373	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—TH—peripheral nervous system neoplasm	8.01e-06	0.000368	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—ERBB2—peripheral nervous system neoplasm	7.9e-06	0.000362	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	7.65e-06	0.000351	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	7.59e-06	0.000348	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	7.45e-06	0.000342	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.3e-06	0.000335	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	7.19e-06	0.00033	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	6.97e-06	0.00032	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	6.74e-06	0.000309	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.65e-06	0.000305	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	6.56e-06	0.000301	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	6.54e-06	0.0003	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	6.42e-06	0.000294	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—NRAS—peripheral nervous system neoplasm	6.01e-06	0.000276	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—AKT1—peripheral nervous system neoplasm	5.99e-06	0.000275	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	5.87e-06	0.000269	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	5.76e-06	0.000264	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—MYC—peripheral nervous system neoplasm	5.6e-06	0.000257	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	5.44e-06	0.00025	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	5.35e-06	0.000246	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	5.25e-06	0.000241	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	5.16e-06	0.000237	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	4.93e-06	0.000226	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	4.6e-06	0.000211	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—AKT1—peripheral nervous system neoplasm	4.6e-06	0.000211	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—HRAS—peripheral nervous system neoplasm	4.4e-06	0.000202	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.39e-06	0.000201	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	4.35e-06	0.0002	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—AKT1—peripheral nervous system neoplasm	4.33e-06	0.000199	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	4.32e-06	0.000198	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—AKT1—peripheral nervous system neoplasm	3.88e-06	0.000178	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—AKT1—peripheral nervous system neoplasm	3.61e-06	0.000166	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	3.53e-06	0.000162	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	3.46e-06	0.000159	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—AKT1—peripheral nervous system neoplasm	3.25e-06	0.000149	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—AKT1—peripheral nervous system neoplasm	3.09e-06	0.000142	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	2.86e-06	0.000131	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	2.05e-06	9.4e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	1.77e-06	8.1e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.58e-06	7.27e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.44e-06	6.63e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	9.53e-07	4.37e-05	CbGpPWpGaD
